• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ESSENTIAL MEDICAL, INC. MANTA 18F; VASCULAR CLOSURE DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ESSENTIAL MEDICAL, INC. MANTA 18F; VASCULAR CLOSURE DEVICE Back to Search Results
Catalog Number 2115
Medical Device Problem Code Obstruction of Flow (2423)
Health Effect - Clinical Code Obstruction/Occlusion (2422)
Date of Event 11/11/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that "after the tavr procedure the physician went to deploy manta, and performed deployment steps properly, the device was deployed and no blood was present at the skin level.A dsa was taken to show there was a partial blockage of the vessel , with limited flow distally.It was the opinion of the vascular surgeon to cut down.The cardiologist was unable to try and remedy the situation with any other steps.A cut down was performed and when the vs was performing the cut down, doppler pulses were present distal to the manta.The manta was explanted.The patient was reported as fine post the procedure.".
 
Additional Manufacturer Narrative
(b)(4).
 
Event or Problem Description
It was reported that "after the tavr procedure the physician went to deploy manta, and performed deployment steps properly, the device was deployed and no blood was present at the skin level.A dsa was taken to show there was a partial blockage of the vessel , with limited flow distally.It was the opinion of the vascular surgeon to cut down.The cardiologist was unable to try and remedy the situation with any other steps.A cut down was performed and when the vs was performing the cut down, doppler pulses were present distal to the manta.The manta was explanted.The patient was reported as fine post the procedure.".
 
Additional Manufacturer Narrative
(b)(4).Complaint verification testing could not be performed as no sample was returned for analysis.A device history record review was performed, and no relevant findings were identified.The additional information indicated that the manta was deployed at the measured deployment depth and was positioned correctly in the vessel.No applied compression was observed during anchor deployment.No excessive downward force with the blue lock advancement tube was observed.Immediate hemostasis was achieved.A surgical cutdown was performed, and the manta was explanted.Without the device to evaluate, the complaint could not be confirmed, and the probable cause could not be determined from the available information.Teleflex will continue to monitor and trend for reports of this nature.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MANTA 18F
Common Device Name
VASCULAR CLOSURE DEVICE
Manufacturer (Section D)
ESSENTIAL MEDICAL, INC.
exton
Manufacturer (Section G)
ESSENTIAL MEDICAL, INC.
260 sierra drive
exton
Manufacturer Contact
kevin don bosco
3015 carrington mill blvd
morrisville, NC 27560
MDR Report Key23704810
Report Number3010252479-2025-00115
Device Sequence Number10691632
Product Code MGB
UDI-Device Identifier10841156111335
UDI-Public(01)10841156111335(11)250806(17)270206(10)73H2500223(21)
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
P180025
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 11/11/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number2115
Device Lot Number73H2500223
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/11/2025
Supplement Date Received by Manufacturer12/19/2025
Initial Report FDA Received Date12/03/2025
Supplement Report FDA Received Date01/05/2026
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured08/06/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NOT REPORTED; NOT REPORTED
Patient SexUnknown
-
-